[CHINA PHARMAS, CHARTER OF THE NOMINATING ANDMPENSATIONMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I.Purpose The Nominating andmpensationmmittee (themmittee) of the Board of Directors of China Pharmas, (thempany) is established to: Formulate goals and objectives relating tompensation payable to thempanys Chief Executive Officer (CEO) and, innsultation with the]
[CHINA PHARMAS, CHARTER OF THE NOMINATING ANDMPENSATIONMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I.Purpose The Nominating andmpensationmmittee (themmittee) of the Board of Directors of China Pharmas, (thempany) is established to: Formulate goals and objectives relating tompensation payable to thempanys Chief Executive Officer (CEO) and, innsultation with the]
[x For the Quarterly Period Ended June 30, 2009 o For the Transition Period from _________ to _________ China Pharma Holdings, Inc. Delaware 73 -1564807 incorporation or organization) (State or other jurisdiction of (IRS Employer Identification No.) nd 2 Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 (Address of principle executive offices) (Zip Code) 898 0086- x o] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharma Holdings, Inc., certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharma Holdings, Inc., certify that: 1) I have reviewed this quarterly report on Form 10-Q of China Pharma Holdings, Inc; 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the "Company") on Form 10-Q for the period ended June 30, 2009 as filed with the Zhilin Li material respects, the financial condition and result of operations of the Company. Zhilin Li Chief Executive Officer EX-32.1 4 cph10qex321063009.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the for the period ended June 30 , 2009 as filed with the Frank Waung Chief Financial Officer EX-32.2 5 cph10qex322063009.htm]
[x For the Quarterly Period Ended June 30, 2009 o For the Transition Period from _________ to _________ China Pharma Holdings, Inc. Delaware 73 -1564807 incorporation or organization) (State or other jurisdiction of (IRS Employer Identification No.) nd 2 Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 (Address of principle executive offices) (Zip Code) 898 0086- x o] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharma Holdings, Inc., certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharma Holdings, Inc., certify that: 1) I have reviewed this quarterly report on Form 10-Q of China Pharma Holdings, Inc; 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the "Company") on Form 10-Q for the period ended June 30, 2009 as filed with the Zhilin Li material respects, the financial condition and result of operations of the Company. Zhilin Li Chief Executive Officer EX-32.1 4 cph10qex321063009.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the for the period ended June 30 , 2009 as filed with the Frank Waung Chief Financial Officer EX-32.2 5 cph10qex322063009.htm]
[x For the Quarterly Period Ended June 30, 2009 o For the Transition Period from _________ to _________ China Pharmas, Delaware 73 -1564807orporation or organization) (State or other jurisdiction of (IRS Employer Identification No.) nd 2 Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 (Address of principle executive offices)] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharmas, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharmas, certify that: 1)I have reviewed this quarterly report on Form 10-Q of China Pharmas,; 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the "Company") on Form 10-Q for the period ended June 30, 2009 filed with the Zhilin Li material respects, the financialndition and result of operations of thempany. Zhilin Li] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the for the period ended June 30 , 2009 filed with the Frank Waung Chief Financial Officer cph10qex322063009.htm 5 EX-32.2]
[x For the Quarterly Period Ended June 30, 2009 o For the Transition Period from _________ to _________ China Pharmas, Delaware 73 -1564807orporation or organization) (State or other jurisdiction of (IRS Employer Identification No.) nd 2 Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 (Address of principle executive offices)] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharmas, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharmas, certify that: 1)I have reviewed this quarterly report on Form 10-Q of China Pharmas,; 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the "Company") on Form 10-Q for the period ended June 30, 2009 filed with the Zhilin Li material respects, the financialndition and result of operations of thempany. Zhilin Li] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the for the period ended June 30 , 2009 filed with the Frank Waung Chief Financial Officer cph10qex322063009.htm 5 EX-32.2]
